After Hours
The risks associated with pre-market and after-hours trading may be slightly higher than the regular market hours. The reason is that extended-hours trading may result in wider spreads for particular security due to lower liquidity and higher volatility as issuers often announce critical financial information outside regular trading hours.
Stocks Info
10x Genomics Inc is listed on the NASDAQ as a member of the Healthcare sector and is a part of the Health Information Services industry. The current market capitalization of 10x Genomics Inc is $1.57B. A total of 2.35 million shares were traded on the day, compared to an average of 2.89M shares.
In the most recent transaction, Saxonov Serge sold 9,348 shares of TXG for 13.79 per share on Aug 22 ’25. After the transaction, the Chief Executive Officer now owns 945,892 company shares. In a previous transaction on Aug 22 ’25, Taich Adam sold 22,315 shares at 13.79 per share. TXG shares that Chief Financial Officer owns now total 309,273.
Among the insiders who sold shares, Hindson Benjamin J. disposed of 7,486 shares on Aug 22 ’25 at a per-share price of $13.79. This resulted in the insider holding 440,888 shares of TXG after the transaction. In another insider transaction, Saxonov Serge bought 9,228 shares at $13.41 per share on Aug 22 ’25.
Though price targets are rarely accurate, they can exert some influence from time to time and were often accepted as valuable by the market. In terms of 52-week highs and lows, TXG has a high of $20.92 and a low of $6.78.
As of this writing, TXG has an earnings estimate of -$0.07 per share for the current quarter. EPS was calculated based on a consensus of 2.0 estimates, with a high estimate of -$0.07 per share and a lower estimate of -$0.07. The company reported an EPS of -$0.02 in the last quarter
Balance Sheet Annually/Quarterly
A balance sheet is a report that shows the company’s assets and liabilities. In addition, it shows how much equity investors have invested in the company. Investors can determine the company’s prospects by calculating its financial ratios based on this information. TXG’s latest balance sheet shows that the firm has $587.45M in Cash & Short Term Investments as of fiscal 2021. There were $81.98M in debt and $110.36M in liabilities at the time. Its Book Value Per Share was $6.21, while its Total Shareholder’s Equity was $817.57M.
Analysts Opinion
It may be riskier to trade before market opening and after market closing than during regular market hours. Since issuers often announce critical financial information outside regular trading hours. Extended-hours trading may result in wider spreads for particular securities due to lower liquidity and higher volatility. Currently, 0 analysts are providing their opinions on the stock. On a scale of 1 to 5, with 1 being Sell and 5 being Buy, the average analyst rating for TXG is Buy with a score of 3.72.
